From Japan with love: Another Tessera in the hypophysitis mosaic

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1865-1868

  Caturegli, Patrizio ^a   Iwama, Shintaro ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G4; IPILIMUMAB;

AUTOIMMUNE PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN DEFICIENCY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HYPOPHYSITIS; JAPAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PATHOPHYSIOLOGY; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

HUMANS; IMMUNOGLOBULIN G; MALE; PITUITARY DISEASES; PITUITARY GLAND;

EID: 84877693299     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1912     Document Type: Review

References (30)

1. Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocr Rev. 2005;26:599-614.
2. Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab. 2011;96:1971-1980.
3. Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003;100:8372-8377.
4. Blansfield JA, Beck KE, Tran K, et al. Cytotoxic T-lymphocyteassociated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother. 2005;28:593-598.
5. Ansell SM, Hurvitz SA, Koenig PA, et al. Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma. Clin Cancer Res. 2009;15:6446-6453.
6. Fong L, Kwek SS, O'Brien S, et al. Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. Cancer Res. 2009;69: 609-615.
7. Royal RE, Levy C, Turner K, et al. Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother. 2010;33:828-833.
8. Lynch TJ, Bondarenko I, Luft A, et al. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol. 2012;30:2046-2054.
9. Goudie RB, Pinkerton PH. Anterior hypophysitis and Hashimoto's disease in a woman. J Pathol Bacteriol. 1962;83:584-585.
10. Simmonds M. Über das vorkommen von riesenzelle in der hypophyse. Virchows Archiv. 1916;223:281-290.
11. Ahmed SR, Aiello DP, Page R, Hopper K, Towfighi J, Santen RJ. Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. J Clin Endocrinol Metab. 1993;76:1499-1504.
12. Deodhare SS, Bilbao JM, Kovacs K, et al. Xanthomatous hypophysitis: a novel entity of obscure etiology. Endocr Pathol. 1999;10: 237-241.
13. van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med. 2004;141: 896-897.
14. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology. 2002;105:9-19.
15. Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119-124.
16. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732-738.
17. Wong S, Lam WY, Wong WK, Lee KC. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol. 2007;38:1720-1723.
18. Fujisawa I. Diagnostic imaging of lymphocytic hypophysitis and IgG4-related disease in the di-encephalo-hypophyseal region. Japanese J Endocrinol. 2009;85:54-55.
19. Hsing MT, Hsu HT, Cheng CY, Chen CM. IgG4-related hypophysitis presenting as a pituitary adenoma with systemic disease. Asian J Surg. 2013;36:93-97.
20. Kaneda M, Sagara A, Hosokawa M, Ise T, Yoshimura M. A case of IgG-4 related multifocal fibrosclerosis with central diabetes insipidus, sclerosing sialoadenitis, and retroperitoneal fibrosis. Naika. 2011;107:175-179.
21. Kotera N, Isogawa A, Uchida L, et al. Case report: IgG4-related hypophysitis presenting with secondary adrenal insufficiency and central diabetes insipidus in a type 1 diabetes patient [in Japanese]. Nihon Naika Gakkai Zasshi. 2011;100:1044-1047.
22. Miyoshi T, Otsuka F, Tsukamoto N, et al. A case of suspected hypothalamo-pituitary dysfunction due to IgG4-related disease. Japanese J Endocrinol. 2008;84:87-89.
23. Nagai K, Hara Y, Shinkai M, et al. A case of IgG4-related disease with deterioration in pulmonary and pituitary involvements during a 10-year clinical course of inflammatory pseudotumor [in Japanese]. Nihon Kokyuki Gakkai zasshi. 2011;49:922-928.
24. Patel SM, Szostek JH. IgG4-related systemic disease in a Native American man. Intern Med. 2011;50:931-934.
25. Shimatsu A, Shimatsu S, Nanba K, Oki Y. IgG4-related infundibulohypophysitis. Ann Rev Diabetes Metab. 2012;199-206.
26. Tachibana O, Tsukada T, Sasagawa Y, et al. Clinico-pathological analysis of hypophysitis in IgG4-related disease. Japanese J Endocrinol. 2010;86:13-15.
27. Taji K, Takamura T, Mouri K, et al. A male case of lymphocytic hypophysitis occurred during the course of IgG4-related disease. Japanese J Endocrinol. 2009;85:42-44.
28. Yukawa E, Nitta N, Taoka T, Morita K, Nishi T, Hara Y. A patient with IgG4-related systemic disease detected due to the presence of optic disc edema. Ganka rinsho kiyo. 2010;3:1207-1210.
29. Hattori Y, Tahara S, Ishii Y, et al. A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab. 2013; 98:1808-1811
30. Turcu AF, Erickson BJ, Lin E Pituitary stalk lesions: the Mayo Clinic experience. J Clin Endocrinol Metab. 2013;98:1812-1818